Showing results (191-200 of 213) with videos related to

Sort By:
Pageof 22
Biochemical Pharmacology|February 25, 2021
Resveratrol enhances trans-intestinal cholesterol excretion through selective activation of intestinal liver X receptor alphaJuan Pang, Huihui Xu, Xu Wang, et al.
Nanoscale|February 20, 2025
One-pot synthesis of long-range aligned nanochannels for Li-ion transfer pathwaysZehan Chen, Isaac Alvarez Moises, Ruth Bruker, et al.
The American Journal of the Medical Sciences|May 31, 2014
Plasma ghrelin concentrations are negatively correlated with urine albumin-to-creatinine ratio in newly diagnosed type 2 diabetesXiaojun Ma, Yanyan Zhao, Qingzhu Wang, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|October 6, 2024
Corosolic acid inhibits EMT in lung cancer cells by promoting YAP-mediated ferroptosisCongcong Zhang, Lingli Gao, Yinghui Zhang, et al.
Breast Cancer Research : BCR|July 3, 2019
A kinase inhibitor screen identifies a dual cdc7/CDK9 inhibitor to sensitise triple-negative breast cancer to EGFR-targeted therapyRonan P McLaughlin, Jichao He, Vera E van der Noord, et al.
Nature Communications|October 9, 2025
Global loss of mountain vegetated landscapes and its impact on biodiversity conservationChao Yang, Haiying Xu, Qingquan Li, et al.
Current Microbiology|November 4, 2022
The Pseudogene BMEA_B0173 Deficiency in Brucella melitensis Contributes to M-epitope Formation and Potentiates Virulence in a Mice Infection ModelGe Zhang, Hao Dong, Yu Feng, et al.
Biotechnology for Biofuels|December 21, 2018
Comparative transcriptome analyses of oleaginous <i>Botryococcus braunii</i> race A reveal significant differences in gene expression upon cobalt enrichmentPengfei Cheng, Chengxu Zhou, Yan Wang, et al.
Acta Pharmaceutica Sinica. B|June 1, 2022
Discovery of ARF1-targeting inhibitor demethylzeylasteral as a potential agent against breast cancerJie Chang, Ruirui Yang, Lifan Chen, et al.
Oncogene|April 3, 2020
Integrative analysis of genomic amplification-dependent expression and loss-of-function screen identifies ASAP1 as a driver gene in triple-negative breast cancer progressionJichao He, Ronan P McLaughlin, Lambert van der Beek, et al.
Pageof 22